Oligomerix
Develops target identification and validation technologies enhancing the drug discovery process for neurodegenerative diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€13m (Public information from Jun 2022)
New York City New York (HQ)
Authorizing premium user...